Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in human immunodeficiency virusâexposed, uninfected infants in Malawi: The BAN study
Clinical Infectious Diseases Aug 12, 2017
Davis NL, et al. – Authors planned to clarify the role of co–trimoxazole preventive therapy (CPT) in reducing leading causes of infectious morbidity. Based on the findings, CPT seemed to play an important role in reducing the leading global causes of morbidity and mortality in the growing population of HIV–exposed, uninfected infants (HEIs) in malaria–endemic resource–limited settings.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
